DeutschNewstral
Article
Bbarrons.com on 2021-05-04 15:25
Pfizer Expects $26B in Covid-19 Vaccine Sales This Year
Related news
Pfizer expects $20b in COVID-19 vaccine revenue this yearSydney Morning Herald
Pfizer expects $26 billion in 2021 sales from COVID vaccineNew York Post
[Ticker] Pfizer expects €22bn in vaccine sales this yeareuobserver.com
Vaccine sales power Pfizer through first quarterSeattle Times- Pfizer Q1 profit, revenue soar on COVID-19 vaccine salesNew York Post
- TPfizer posts narrower Q3 loss amid slumping Covid vaccine salesthestreet.com
- Pfizer hikes 2021 outlook after vaccine boosts sales, profitSeattle Times
Pfizer expects Covid vaccine demand for yearsBBC
Pfizer Triggers $28 Billion Stock Plunge After Warning Covid Vaccine Sales May Disappoint This YearForbes- Pfizer expects $15bn sales of Covid-19 vaccineBBC
Pfizer vaccine brought in more than $13B in sales - Tue, 03 May 2022 PSTThe Spokesman-Review- FPfizer expects $15bn in Covid vaccine revenue this yearft.com
- Vaccine sales power Pfizer through first quarter - Tue, 04 May 2021 PSTThe Spokesman-Review
Pfizer tops Q1 forecasts; vaccine sales slide as expectedseattletimes.com- Pfizer tops Q3 forecasts as total COVID vaccine sales soarSeattle Times
Pfizer records $22bn COVID-19 vaccine sales in 2021punchng.com- BPfizer Says It Will Now Sell $33.5 Billion of Its Covid-19 Vaccine This Year3 min readbarrons.com
Pfizer CEO expects 3rd dose of vaccine will be necessary within a yeartimesofisrael.com